Insider Trading: Heska Corp (HSKA.W)
HSKA.W on CBOE When Trading NASDAQ Global Select Market
8.87USD
10 Apr 2013
8.87USD
10 Apr 2013
Price Change (% chg)
$0.82 (+10.19%)
$0.82 (+10.19%)
Prev Close
$8.05
$8.05
Open
$8.87
$8.87
Day's High
$8.87
$8.87
Day's Low
$8.87
$8.87
Volume
100
100
Avg. Vol
2
2
52-wk High
$11.37
$11.37
52-wk Low
$7.76
$7.76
BENT MICHAEL A
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 27 Dec 2012 | Buy | 3,000 | $3.40 | 9,773 |
| 26 Sep 2012 | Sell | 3,453 | $9.12 | 6,773 |
| 26 Sep 2012 | Buy | 4,500 | $7.00 | 6,773 |
| 26 Mar 2012 | Sell | 2,238 | $11.50 | 5,499 |
| 26 Mar 2012 | Buy | 2,600 | $9.90 | 5,499 |
Institutional Holders
| % Shares Owned: | 29.86% |
| # of Holders: | 33 |
| Total Shares Held: | 1,733,064 |
| 3 Mo. Net Change: | 4,896 |
| # New Positions: | 2 |
| # Closed Positions: | 3 |
| # Increased Positions: | 12 |
| # Reduced Positions: | 12 |
| # Net Buyers: | 0 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Robert Grieve |
61 | 2000 | Chairman of the Board, Chief Executive Officer |
Kevin Wilson |
41 | 2013 | President, Chief Operating Officer |
Jason Napolitano |
44 | 2009 | Chief Financial Officer, Executive Vice President, Secretary |
Michael McGinley |
52 | 2013 | President - Biologicals & Pharmaceuticals |
Steven Asakowicz |
47 | 2013 | Executive Vice President - Companion Animal Health Sales |
Rodney Lippincott |
39 | 2013 | Executive Vice President - Companion Animal Health Sales |
Nancy Wisnewski |
50 | 2011 | Executive Vice President - Product Development and Customer Support |
Michael Bent |
58 | 2002 | Vice President, Principal Accounting Officer, Controller |
William Aylesworth |
70 | 2010 | Lead Independent Director |
Peter Eio |
71 | 2002 | Independent Director |
G. Irwin Gordon |
62 | 2001 | Independent Director |
Sharon Riley |
52 | 2011 | Independent Director |
Carol Wrenn |
52 | 2013 | Independent Director |

